Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption
Authors
Keywords
absorption, atazanavir, food effects, PPIs, weakly basic drugs
Journal
PHARMACEUTICAL RESEARCH
Volume 34, Issue 3, Pages 619-628
Publisher
Springer Nature
Online
2016-12-28
DOI
10.1007/s11095-016-2090-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Use of Betaine HCl to Enhance Dasatinib Absorption in Healthy Volunteers with Rabeprazole-Induced Hypochlorhydria
- (2014) Marc R. Yago et al. AAPS Journal
- Pharmacokinetic Enhancers in HIV Therapeutics
- (2014) Kajal B. Larson et al. CLINICAL PHARMACOKINETICS
- pH-Dependent Drug–Drug Interactions for Weak Base Drugs: Potential Implications for New Drug Development
- (2014) L Zhang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In Vitro and In Situ Evaluation of pH-Dependence of Atazanavir Intestinal Permeability and Interactions with Acid-Reducing Agents
- (2014) Olena Kis et al. PHARMACEUTICAL RESEARCH
- Gastric Reacidification with Betaine HCl in Healthy Volunteers with Rabeprazole-Induced Hypochlorhydria
- (2013) Marc R. Yago et al. MOLECULAR PHARMACEUTICS
- Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical Development
- (2013) Gillian S. Smelick et al. MOLECULAR PHARMACEUTICS
- Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?
- (2012) N R Budha et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- BDDCS Applied to Over 900 Drugs
- (2011) Leslie Z. Benet et al. AAPS Journal
- Effects of the H2-Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected Patients
- (2011) Xiaodong Wang et al. AIDS PATIENT CARE AND STDS
- Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
- (2011) Jeroen Walravens et al. CLINICAL PHARMACOKINETICS
- Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects
- (2010) Li Zhu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition
- (2010) F. Josephson JOURNAL OF INTERNAL MEDICINE
- The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
- (2009) Sarah Shugarts et al. PHARMACEUTICAL RESEARCH
- Drug Interactions between HIV Protease Inhibitors and Acid-Reducing Agents
- (2008) Ronald W Falcon et al. CLINICAL PHARMACOKINETICS
- Effects of Acid-Reducing Agents on the Pharmacokinetics of Lopinavir/Ritonavir and Ritonavir-Boosted Atazanavir
- (2008) Cheri E. Klein et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now